MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01775cam a2200313 4500 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9289012579 |
| 035 ## - |
|---|
| -- |
(Sirsi) a42097 |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 748 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
880210s1985 eng |
| 111 2# - MAIN ENTRY--MEETING NAME |
|---|
| Meeting name or jurisdiction name as entry element |
European Symposium on Clinical Pharmacological Evaluation in Drug Control |
| Number of part/section/meeting |
(11th: |
| Date of meeting |
1982: |
| Location of meeting |
Schlangenbad, Germany, Federal Republic of) |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Drugs in general practice : |
| Remainder of title |
report on a WHO meeting, Schlangenbad, 19-22 October 1982. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Copenhagen : |
| Name of publisher, distributor, etc. |
WHO Regional Office for Europe, |
| Date of publication, distribution, etc. |
1985. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
45 p. |
| 440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
EURO reports and studies ; |
| Volume/sequential designation |
91 |
| 501 ## - WITH NOTE |
|---|
| With note |
Korean edition with: The Use of essential drugs. WHO technical report series no. 867. |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
A critical assessment of factors influencing the drug prescribing practices of general practitioners. Because of the problems created by overutilization of medical resources, particular attention is given to factors that can leadto the overprescribing of drugs. Topics range from an explanation of why doctors may allow their practices to be dominated by drug prescribing, through the impact of information supplied verbally and in print by the pharmaceutical industry, to the reasons for poor communication between drug regulatory agencies and physicians. A section on the use of prescription audits is also included. |
| 535 ## - |
|---|
| -- |
DC.EURO |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
eng with summaries in fre ger rus. |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
kor. |
| 561 ## - OWNERSHIP AND CUSTODIAL HISTORY |
|---|
| History |
WHO monograph |
| 565 8# - CASE FILE CHARACTERISTICS NOTE |
|---|
| Number of cases/variables |
ICP/PHB 009(11) |
| 596 ## - |
|---|
| -- |
4 |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Prescriptions, Drug. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Family practice. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Pharmacology, Toxicology and Clinical Technology. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
World Health Organization. |
| Subordinate unit |
Regional Office for Europe. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://apps.who.int/iris/">https://apps.who.int/iris/</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
NLM Classification Scheme |
| Koha item type |
Books |
